Logo for Aptose Biosciences Inc

Aptose Biosciences Investor Relations Material

Latest events

Logo for Aptose Biosciences Inc

Q4 2023

Aptose Biosciences
Logo for Aptose Biosciences

Q4 2023

26 Mar, 2024
Logo for Aptose Biosciences

Q3 2023

9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Aptose Biosciences Inc

Access all reports
Aptose Biosciences Inc., a biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. In addition, the company is developing product candidates using Allogeneic Natural Killer Cell Pharmacological Chimeric Receptors (NK-PRRs) to treat cancer, with NK-PRR strategies designed to target specific tumor antigens. The company's mission is to deliver therapies that fit the precise characteristics of individual patients, by providing tailor-made, autologous treatments that harness a patient’s own immune system cells to fight disease.